Table 1 Baseline characteristics in patients with chronic kidney disease and controls
From: Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro
Baseline characteristics | Controls | CKD | P-value |
|---|---|---|---|
N = 19 | N = 23 | ||
Age, y (IQR) | 62 (48-71) | 78 (64-83) | 0.043 |
Male, n (%) | 13 (68.4) | 15 (65.2) | 0.755 |
Hemoglobin, mmol/L (IQR) | 9.4 (9.0-9.9) | 7.2 (6.7-7.8) | 0.006 |
Hematocrit, L/L (IQR) | 0.44 (0.43-0.47) | 0.36 (0.34-0.38) | 0.001 |
Platelet count, 109/L (IQR) | 210 (150-240) | 187 (160-225) | 0.223 |
Hemodialysis, n (%) | NA | 14 (60.9) | - |
Cardiorenal syndrome, n (%) | NA | 9 (39.1) | - |
EPO use, n (%) | NA | 5 (21.7) | - |
Aspirin use, n (%) | 0 | 11 (47.8) | - |